These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 7881748

  • 1. Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium.
    Ghaleh B, Dubois-Randé JL, Hittinger L, Giudicelli JF, Berdeaux A.
    Br J Pharmacol; 1995 Jan; 114(2):496-502. PubMed ID: 7881748
    [Abstract] [Full Text] [Related]

  • 2. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
    Giudicelli JF, la Rochelle CD, Berdeaux A.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
    [Abstract] [Full Text] [Related]

  • 3. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A, Bergamaschi M, Gromo G, Nonaka K, Mizrahi J.
    J Cardiovasc Pharmacol; 1995 Nov; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [Abstract] [Full Text] [Related]

  • 4. Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism.
    la Rochelle CD, Richard V, Dubois-Randé JL, Roupie E, Giudicelli JF, Hittinger L, Berdeaux A.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1091-6. PubMed ID: 1469622
    [Abstract] [Full Text] [Related]

  • 5. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K, Yamada H, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [Abstract] [Full Text] [Related]

  • 6. Coronary effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs.
    Hashimoto K, Kinoshita M, Ohbayashi Y.
    Cardiovasc Drugs Ther; 1991 Feb; 5(1):131-8. PubMed ID: 1827988
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of nitrovasodilators, K(+)-channel openers, and nicorandil on large and small coronary arteries in conscious dogs.
    Berdeaux A, Drieu la Rochelle C, Richard V, Giudicelli JF.
    J Cardiovasc Pharmacol; 1992 Feb; 20 Suppl 3():S17-21. PubMed ID: 1282171
    [Abstract] [Full Text] [Related]

  • 8. Protection by nicorandil against the dysfunction of the central vagal baroreflex system following transient global cerebral ischaemia in dogs.
    Kurihara J, Ochiai N, Kato H.
    Br J Pharmacol; 1993 Aug; 109(4):1263-7. PubMed ID: 8401937
    [Abstract] [Full Text] [Related]

  • 9. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
    Imagawa J, Akima M, Nabata H, Taira N.
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
    [Abstract] [Full Text] [Related]

  • 10. Effects of 2-nicotinamidethyl nitrate (SG-75) and/or nitroglycerin on systemic hemodynamics and coronary blood flow in conscious dogs.
    Mizukami M, Tomoike H, Inouh T, Watanabe K, Kikuchi Y, Nakamura M.
    Arzneimittelforschung; 1981 Jan; 31(8):1244-7. PubMed ID: 6457606
    [Abstract] [Full Text] [Related]

  • 11. Effects of long-term nicorandil application on coronary arteries in conscious dogs.
    Huckstorf C, Bassenge E.
    J Cardiovasc Pharmacol; 1992 Jan; 20 Suppl 3():S29-33. PubMed ID: 1282173
    [Abstract] [Full Text] [Related]

  • 12. Effects of nicorandil on the conductive coronary artery of the dog.
    Imai S, Nakazawa M, Takeda K, Nakagawa Y, Katano Y, Tsukada T, Nabata H, Ushijima T.
    J Cardiovasc Pharmacol; 1987 Jan; 10 Suppl 8():S10-6. PubMed ID: 2447415
    [Abstract] [Full Text] [Related]

  • 13. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T, Iwai T, Haruta K, Takeda K.
    Arch Int Pharmacodyn Ther; 1996 Jan; 331(3):273-84. PubMed ID: 9124999
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.
    Nakae I, Quan L, Hashimoto K, Sugimoto Y, Tsutamoto T, Kinoshita M.
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):137-45. PubMed ID: 8086324
    [Abstract] [Full Text] [Related]

  • 15. Hydralazine dilates large epicardial coronary arteries in conscious dogs through an endothelium-independent mechanism.
    Drieu la Rochelle C, Dubois-Randé JL, Hittinger L, Richard V, Berdeaux A, Giudicelli JF.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):315-8. PubMed ID: 7511763
    [Abstract] [Full Text] [Related]

  • 16. Effects of nicorandil on large epicardial coronary artery in conscious dogs.
    Yamada A, Tomoike H, Hayashi Y, Nishijima H, Nakamura M.
    Arzneimittelforschung; 1987 Nov; 37(11):1252-5. PubMed ID: 2964242
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of nicorandil, pinacidil and nitroglycerin on hypoxic and hypercapnic pulmonary vasoconstriction in the isolated perfused lung of rat.
    Dumas M, Dumas JP, Rochette L, Advenier C, Giudicelli JF.
    Br J Pharmacol; 1996 Feb; 117(4):633-8. PubMed ID: 8646407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA, Stork AP.
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.